Akebia Therapeutics (AKBA) Shares Outstanding (Entity) (2013 - 2026)
Akebia Therapeutics (AKBA) Shares Outstanding (Entity) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | 4.44 Bn |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | 1.17 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | 414.15 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 42.68 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 1.15 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 101.60 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 499.55 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | 834.66 Mn |
| 10 | Akebia Therapeutics | 240.57 Mn | 85.02 Mn | 38.70 Mn | 271.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 271.74 Mn |
| Mar 31, 2026 | 267.90 Mn |
| Dec 31, 2025 | 265.42 Mn |
| Sep 30, 2025 | 265.23 Mn |
| Jun 30, 2025 | 263.04 Mn |
| Mar 31, 2025 | 261.64 Mn |
| Dec 31, 2024 | 224.85 Mn |
| Sep 30, 2024 | 211.54 Mn |
| Jun 30, 2024 | 209.93 Mn |
| Mar 31, 2024 | 209.45 Mn |
| Dec 31, 2023 | 194.58 Mn |
| Sep 30, 2023 | 188.31 Mn |
| Jun 30, 2023 | 188.13 Mn |
| Mar 31, 2023 | 185.84 Mn |
| Dec 31, 2022 | 184.14 Mn |
| Sep 30, 2022 | 183.95 Mn |
| Jun 30, 2022 | 183.70 Mn |
| Mar 31, 2022 | 183.39 Mn |
| Dec 31, 2021 | 177.00 Mn |
| Sep 30, 2021 | 174.55 Mn |